Charles River Laboratories International, Inc. News Headlines

CRL 
$59.26
*  
0.42
0.7%
Get CRL Alerts
*Delayed - data as of Aug. 20, 2014 13:14 ET  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CRL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Charles River Laboratories International (CRL) Shares Cross Below 200 DMA
5/22/2014 4:19:24 PM - BNK Invest

Setback for Novartis' RLX030 - Analyst Blog
5/16/2014 5:10:00 PM - Zacks.com

Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog
5/9/2014 1:41:00 PM - Zacks.com

Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 1:43:01 PM - Zacks.com

Biotech Stock Roundup: Endocyte Tumbles & Merrimack Soars on Pipeline News - Analyst Blog
5/7/2014 9:34:01 AM - Zacks.com

Dynavax Reports In Line Q1 Results - Analyst Blog
5/6/2014 11:50:01 AM - Zacks.com

Acorda Down on Plumiaz CRL - Analyst Blog
5/5/2014 3:12:01 PM - Zacks.com

Charles River Laboratories (CRL) is now in Oversold Territory - Tale of the Tape
5/2/2014 9:50:01 AM - Zacks.com

CRL for The Medicines Co.'s Cangrelor - Analyst Blog
5/1/2014 4:05:01 PM - Zacks.com

Charles River Beats on Earnings, Guidance Upped - Analyst Blog
5/1/2014 3:34:01 PM - Zacks.com

Charles River Laboratories International Breaks Below 200-Day Moving Average - Notable for CRL
5/1/2014 11:27:34 AM - BNK Invest

Express Scripts Misses Earnings, Guides Low - Analyst Blog
4/30/2014 11:50:01 AM - Zacks.com

Is Charles River Laboratories (CRL) Stock a Solid Choice Right Now? - Tale of the Tape
4/30/2014 8:49:01 AM - Zacks.com

Charles River Laboratories: A Well-Positioned CRO Due To Blossom In Pre-Clinical Services
4/29/2014 3:26:00 PM - Seeking Alpha

Progenics Finishes Patient Enrollment - Analyst Blog
4/25/2014 7:00:01 PM - Zacks.com

Wider-than-Expected Q1 Loss at AMAG - Analyst Blog
4/25/2014 11:00:01 AM - Zacks.com

Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
4/16/2014 4:10:01 PM - Zacks.com

Regulatory Update from Impax - Analyst Blog
4/15/2014 4:55:01 PM - Zacks.com

Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog
4/15/2014 4:45:01 PM - Zacks.com

Sanofi to File for Lemtrada Approval Again - Analyst Blog
4/8/2014 7:09:01 PM - Zacks.com

Must-know catalysts and valuation for ICON
4/4/2014 1:00:00 PM - Market Realist

Why analyst expectation of a margin compression is unreasonable
4/4/2014 9:00:00 AM - Market Realist

Market overview for CROs suggest healthy growth for ICON
4/3/2014 4:22:00 PM - Market Realist

MannKind Down on FDA's Briefing Document - Analyst Blog
3/31/2014 4:45:01 PM - Zacks.com

CHMP Backs Eli Lilly's Diabetes Drug - Analyst Blog
3/24/2014 4:30:01 PM - Zacks.com